ArSéMaG
Turnover is estimated at about €130,000, probably between €59,000 and €310,000. The micro format does not state turnover.
Balance sheet
balance sheet total €40,807 on 31-12-2025in euro
in euro
Position in the sector
25.3%
Higher than 23% of the 21,368 companies filing micro accounts in human health (NACE 86) in 2025.
0.74
Higher than 11% of the 20,917 companies filing micro accounts in human health (NACE 86) in 2025.
6.0%
Higher than 17% of the 21,218 companies filing micro accounts in human health (NACE 86) in 2025.
Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 202214 months |
|---|---|---|---|---|---|
| 16,727 | 13,287 | 8,903 | 13,943 | ||
| 14,564 | 12,683 | 9,228 | 12,437 | ||
| 2,950 | 0 | 0 | 63,399 | ||
| 5,663 | 4,887 | -2,192 | - | ||
| -6,642 | -12,182 | -18,851 | -22,123 | ||
| 25.3% | 17.3% | 13.5% | 14.7% | ||
| 0.74 | 0.55 | 0.38 | 0.40 | ||
| 0.60 | 0.38 | 0.26 | 0.26 | ||
| 2.95 | 4.77 | 6.43 | 5.81 | ||
| 23.6% | 7.0% | -39.9% | 39.6% | ||
| 6.0% | 1.2% | -5.4% | 5.8% | ||
| 62.37 | 35.60 | over 100 | 56.71 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 202214 months |
|---|---|---|---|---|---|
| Balance sheet: assets | |||||
20/58 |
40,807 | 45,532 | 54,500 | 69,930 | |
21/28 |
21,558 | 30,739 | 42,870 | 55,028 | |
21 |
630 | 1,170 | 1,710 | 2,250 | |
22/27 |
18,003 | 26,644 | 38,236 | 49,853 | |
23 |
4,179 | 5,157 | 6,135 | 7,139 | |
24 |
13,824 | 21,487 | 32,100 | 42,713 | |
28 |
2,925 | 2,925 | 2,925 | 2,925 | |
29/58 |
19,249 | 14,793 | 11,629 | 14,902 | |
3 |
3,661 | 4,609 | 3,741 | 5,201 | |
30/36 |
3,661 | 4,609 | 3,741 | 5,201 | |
40/41 |
40 | - | 2,479 | 1,411 | |
40 |
40 | - | 2,479 | 900 | |
41 |
- | - | - | 511 | |
54/58 |
15,010 | 9,347 | 4,460 | 6,652 | |
490/1 |
538 | 837 | 949 | 1,637 | |
| Balance sheet: equity and liabilities | |||||
10/49 |
40,807 | 45,532 | 54,500 | 69,930 | |
10/15 |
10,320 | 7,888 | 7,336 | 10,265 | |
10/11 |
6,200 | 6,200 | 6,200 | 6,200 | |
14 |
4,120 | 1,688 | 1,136 | 4,065 | |
17/49 |
30,487 | 37,644 | 47,163 | 59,664 | |
17 |
4,595 | 10,669 | 16,684 | 22,639 | |
170/4 |
4,595 | 10,669 | 16,684 | 22,639 | |
42/48 |
25,892 | 26,975 | 30,480 | 37,025 | |
42 |
6,074 | 6,014 | 5,955 | 5,896 | |
44 |
1,624 | 748 | 817 | 1,410 | |
440/4 |
1,624 | 748 | 817 | 1,410 | |
45 |
5,680 | 3,892 | 5,434 | 4,800 | |
450/3 |
5,680 | 3,892 | 5,434 | 4,800 | |
47/48 |
12,514 | 16,322 | 18,275 | 24,919 | |
| Income statement | |||||
9900 |
17,440 | 13,987 | 9,517 | 14,959 | |
630 |
12,131 | 12,131 | 12,157 | 8,371 | |
640/8 |
712 | 700 | 614 | 1,016 | |
9901 |
4,596 | 1,156 | -3,254 | 5,572 | |
75/76B |
59 | 20 | 195 | 0 | |
75 |
59 | 20 | 195 | 0 | |
65/66B |
268 | 373 | 50 | 246 | |
65 |
268 | 373 | 50 | 246 | |
9903 |
4,387 | 803 | -3,109 | 5,326 | |
67/77 |
1,954 | 251 | -179 | 1,261 | |
9904 |
2,433 | 551 | -2,929 | 4,065 | |
9905 |
2,433 | 551 | -2,929 | 4,065 | |
| Appropriation of the result | |||||
9906 |
4,120 | 1,688 | 1,136 | 4,065 | |
14P |
1,688 | 1,136 | 4,065 | - | |
| Document | |||||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 25-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankThe accounts were filed on 25-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00421446.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible fixed assets | €2,950 | - | - | €57,774 |
| Intangible fixed assets | - | - | - | €2,700 |
| Financial fixed assets | - | - | - | €2,925 |
| €12,131 | €12,131 | €12,157 | €8,371 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Insights on ArSéMaG
The operating result for 2025 is nearly 4 times that of 2024 and the highest since 2023. It is the second rise in a row.
Debt's share of the balance-sheet total falls from 82.7% to 74.7%. Equity is higher and debt is lower.